Prevalence of eligibility for dual GIP/GLP-1 receptor agonists among non-diabetic and overweight adults - a Portuguese community-based study
11 May 2026 (08:30 - 09:47)
Organised by: 
Abstract
Slides
About the speaker
Sao Joao University Hospital Centre, Porto (Portugal)
6 More presentations in this session
Doctor A. Martins (Leiria, PT)
Doctor C. Chandramouli (Singapore, SG)
Doctor Z. Wright (Winston Salem, US)
Doctor R. Coenen Chelu (Rotterdam, NL)
Associate Professor V. Medovchshikov (Aktobe, KZ)
Access the full session
The Event
Heart Failure 2026
11 May 2026
08:30 CET
You may be interested in
Congress Session
Congress Presentation
